| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/25/2003 | US20030237101 Stem cell factor; modulation of gene expression |
| 12/25/2003 | US20030236632 Biomarkers for breast cancer |
| 12/25/2003 | US20030236395 Antiproliferative agents; anticancer agents |
| 12/25/2003 | US20030236392 Genetic engineering; polypeptide library |
| 12/25/2003 | US20030236389 Proteins, polynucleotides encoding them and methods of using the same |
| 12/25/2003 | US20030236300 Releasing confined proteins; administering synergistic mixture of curcumin and enzyme inhibitor |
| 12/25/2003 | US20030236260 Antiarthritic agents; autoimmune diseases; anticholesterol agents; cardiovascular disorders; antiinflammatory agents |
| 12/25/2003 | US20030236213 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
| 12/25/2003 | US20030236212 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
| 12/25/2003 | US20030236209 Compositions and methods for the therapy and diagnosis of lung cancer |
| 12/25/2003 | US20030236195 Isolated from Bacillus; for controlling Lepidotera |
| 12/25/2003 | US20030235905 Detectors; using light radiation for measuring |
| 12/25/2003 | US20030235901 Detoxification using amylase; drug screening analysis |
| 12/25/2003 | US20030235900 Anticancer agents |
| 12/25/2003 | US20030235899 Catalytic domain of the human effector cell cycle checkpoint protein kinase Chk1 materials and methods for identification of inhibitors thereof |
| 12/25/2003 | US20030235898 Nematode GS-like sequences |
| 12/25/2003 | US20030235890 Antiinflammatory agents; oral diseases; Alzheimer's disease; nucleic acid with detectable label |
| 12/25/2003 | US20030235879 Culture medium and method for detecting thermonuclease-positive staphylococci |
| 12/25/2003 | US20030235878 Identifying modulator of ATP-binding cassette transporter A1 (ABCA1) protein for use in treatment of atherosclerosis |
| 12/25/2003 | US20030235877 Conjugates of haptens to beta-lactam derivatives and their use for detecting and/or quantifying haptens in solution and device for implementation thereof |
| 12/25/2003 | US20030235876 Novel Bartonella antigen lysate extracts for use in ELISA diagnostic |
| 12/25/2003 | US20030235873 Process for detecting enzyme activity in an immunoassay |
| 12/25/2003 | US20030235865 Kit for monitoring and measuring phosphorylation and dephosphorylation; immunoassay; high throughput asssay |
| 12/25/2003 | US20030235859 Enhance the signal-to-noise ratio by providing the substrate in donor particles with an aqueous core in the presence of osmotic pressure |
| 12/25/2003 | US20030235857 Regulation of fungal gene expression |
| 12/25/2003 | US20030235855 Assay for the detection of paclitaxel resistant cells in human tumors |
| 12/25/2003 | US20030235854 Methods for analyzing a nucleic acid |
| 12/25/2003 | US20030235853 Solid phase synthesis; for drug screening |
| 12/25/2003 | US20030235850 Method for in vivo identification of intracellular epitopes |
| 12/25/2003 | US20030235849 Using rolling circle replication to propagate preferential nucleotide sequences; strand displacement amplification; DNA sequencing |
| 12/25/2003 | US20030235848 Using oligonucleotide sequences to identify polymorphism in cytochrome p450 (CYD-2D6) gene sequences; DNA fingerprinting |
| 12/25/2003 | US20030235847 Using DNA primers to identifying polymorphisms in sclerostin gene region (SRP) and diagnose bones disorders such as osteoporosis |
| 12/25/2003 | US20030235845 Directing splicing of messenger RNA associated with dystrophin protein for diagnosis and treatment of muscular dystrophy |
| 12/25/2003 | US20030235844 Monitoring replication and separation of nucleotide sequences during cloning, gene expression analysis, DNA sequencing, genetic mapping and genome diagnostics electrophoresis. |
| 12/25/2003 | US20030235842 Map |
| 12/25/2003 | US20030235841 Identifying allelic mutations associate with nervous system disorders; restriction fragment length polymorphisms |
| 12/25/2003 | US20030235840 Multiparametric fluorescence in situ hybridization |
| 12/25/2003 | US20030235838 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia |
| 12/25/2003 | US20030235837 Comprises probes and primers for classifying parasitic microorganisms; restriction fragment length polymorphisms; variable number of tandem repeat sequences |
| 12/25/2003 | US20030235836 Labeling of objects to be identified consisting of at least one DNA fragment |
| 12/25/2003 | US20030235835 Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits |
| 12/25/2003 | US20030235834 Diagnosing respiratory disorders via presence of allelic aberrations in cystic fibrosis transmembrane conductance regulator (CFTR) gene; restriction fragment length polymorphisms |
| 12/25/2003 | US20030235832 Multiplexed analysis by chromatographic separation of molecular tags |
| 12/25/2003 | US20030235831 Nucleic acids, proteins, and antibodies |
| 12/25/2003 | US20030235830 Partitioning endogenous cellular transcription products and associated proteins for generating gene expression profile of cells |
| 12/25/2003 | US20030235829 Nucleic acids, proteins, and antibodies |
| 12/25/2003 | US20030235828 Methods and compositions for high throughput identification of protein/nucleic acid binding pairs |
| 12/25/2003 | US20030235827 Methods and compositions for monitoring primer extension and polymorphism detection reactions |
| 12/25/2003 | US20030235826 Gene and protein specific for excitable tissues |
| 12/25/2003 | US20030235824 Antireflective coatings for high-resolution photolithographic synthesis of DNA array |
| 12/25/2003 | US20030235823 Nucleotide sequences that code for torsin genes, torsin proteins, and methods of using the same to treat protein-aggregation |
| 12/25/2003 | US20030235822 Computer software for mismatch discrimination based on thermodynamics |
| 12/25/2003 | US20030235820 Detecting and identifying tumor related transcripts associated with cancer; screening and monitoring antiproliferative agents |
| 12/25/2003 | US20030235819 Comprises oligonucleotide sequences for detecting and identifying allelic mutation in tumor suppressor gene which leads to breast and ovarian cancer; anticarcinogenic agents; gene therapy |
| 12/25/2003 | US20030235818 Identifying amino acid sequences which mimic epitopes of target proteins such as shigella toxin, hepatitis viral coat protein and anthrax lethal factor for development of genetic vacines |
| 12/25/2003 | US20030235812 Diagnosing diabetic disorders via impaired insulin secretion, decreased adenine triphosphate biosynthesis and increased levels of reactive oxygen species |
| 12/25/2003 | US20030235592 Moraxella catarrhalis protein, gene sequence and uses thereof |
| 12/25/2003 | US20030235573 Mutant protein comprising fragment of mutant dimethylarginine dimethylaminohydrolase (DDAH) enzyme, where fragment possesses affinity for asymmetric N,N-dimethylarginine (ADMA) and is deficient in hydrolyzing ADMA to citrulline |
| 12/25/2003 | US20030235558 Contacting a compound with a sample containing p62 and ubiquitin, determining level of p62/ubiquitin binding under normal conditions and in the presence of the compound and comparing the two levels |
| 12/25/2003 | US20030235535 Administering a Prokineticin 2 receptor antagonist or agonist; control internal body clock and functions |
| 12/25/2003 | US20030235533 A nucleic acid sequence that is expressed by human prostate cancer cells, an expressed antigen that elicits antibodies, diagnostic kit comprising a monoclonal antibody is used to detect prostate cancer |
| 12/25/2003 | US20030235531 Method of using metaloporphyrins for treatment of arteriosclerotic lesions |
| 12/25/2003 | CA2432864A1 Method for the impedimetric detection of one or more analytes in a sample, and device for use therein |
| 12/24/2003 | WO2003107270A2 Metabolic phenotyping |
| 12/24/2003 | WO2003107249A1 Method for predicting a drug transport capability by abcg2 polymorphisms |
| 12/24/2003 | WO2003107144A2 Systems and methods for predicting oligonucleotide melting temperatures (tms) |
| 12/24/2003 | WO2003107011A1 Method of assay with sulfonic acid compound and nitro compound |
| 12/24/2003 | WO2003107008A2 DIAGNOSTIC POLYMORPHISM OF 11ß-HYDROXYSTEROID DEHYDROGENASE USEFUL FOR IDENTIFYING RISK OF DEVELOPING ALZHEIMER'S DISEASE |
| 12/24/2003 | WO2003107006A1 Oxaliplatin anti-resistance agent |
| 12/24/2003 | WO2003107002A1 Chfr protein-catalyzed polyubiquitination of aurora kinase a and aurora kinase b |
| 12/24/2003 | WO2003106997A1 Oligosaccharide biomarkers for mucopolysaccharidoses and other related disorders |
| 12/24/2003 | WO2003106981A1 "an improved optical sensor and method for measuring concentration of a chemical constituent using its intrinsic optical absorbance" |
| 12/24/2003 | WO2003106974A2 Diagnosis and treatment of chemoresistant tumors |
| 12/24/2003 | WO2003106970A2 P27 prevents cellular migration |
| 12/24/2003 | WO2003106968A2 Test strip for detection of analyte and methods of use |
| 12/24/2003 | WO2003106966A2 Miniature biological fuel cell that is operational under physiological conditions, and associated devices and methods |
| 12/24/2003 | WO2003106943A1 Metal coated nanocrystalline silicon as an active surface enhanced raman spectroscopy (sers) substrate |
| 12/24/2003 | WO2003106714A1 Compositions and methods for detecting hepatitis b virus |
| 12/24/2003 | WO2003106713A1 Antisense modulation of stati expression |
| 12/24/2003 | WO2003106710A1 Correction method, apparatus and recording medium on oligonucleotide microarray using principal component analysis |
| 12/24/2003 | WO2003106709A1 Methods for detecting polymorphisms using arms or rflp |
| 12/24/2003 | WO2003106708A1 Methods for the detection of polymorphisms in the human oatpf gene |
| 12/24/2003 | WO2003106707A1 Method for detecting increased susceptibility to tumours |
| 12/24/2003 | WO2003106706A2 Identification of tissue/cell specific marker genes and use thereof |
| 12/24/2003 | WO2003106705A1 In vitro screening of cellular events using 3d cell culture systems |
| 12/24/2003 | WO2003106704A1 Method for identifying intracellular transport modulators by measuring the expression or activity of neutral sphingomyelinase |
| 12/24/2003 | WO2003106703A2 Homogenous assay for enzymatic activity |
| 12/24/2003 | WO2003106702A1 Method of measuring glucose concentration and glucose sensor with the use of glucose dehydrogenase |
| 12/24/2003 | WO2003106700A1 Method of cell culture |
| 12/24/2003 | WO2003106699A1 Bacterial test method by glycated label binding |
| 12/24/2003 | WO2003106696A2 Methods and devices for the detection of pathogenic microorganisms and their antimicrobial susceptilbility |
| 12/24/2003 | WO2003106692A2 Methods for the identification of all-antigens and their use for cancer therapy and transplantation |
| 12/24/2003 | WO2003106684A2 A method for simultaneous production of multiple proteins; vectors and cells for use therein |
| 12/24/2003 | WO2003106680A1 Method for amplifying rna, and its use in expression profiling |
| 12/24/2003 | WO2003106678A1 Dna amplification and sequencing in collapsible emulsions |
| 12/24/2003 | WO2003106676A1 Probes for identifying microorganism and identification method using the same |
| 12/24/2003 | WO2003106669A1 Purified pkb ser 473 kinase and uses thereof |
| 12/24/2003 | WO2003106660A2 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 12/24/2003 | WO2003106659A2 Aptamer-toxin molecules and methods for using same |
| 12/24/2003 | WO2003106653A2 Recombinant polynucleotides encoding pro-geldanamycin producing polyketide synthases and accessory proteins, and uses thereof |